ClinicalTrials.gg
Not yet recruitingNCT05173064Updated Jun 4, 2026

Effects of a Machine Learning-based Lower Limb Exercise Training System for Knee Pain

An interventional study of The AI-powered Technological Surrogate Physiotherapist and Face-to-face physiotherapist-supervised exercise program in Pain and Knee Osteoarthritis, sponsored by The University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 17 studies in Pain by The University of Hong Kong — 4 open to participants now, 4 under way, 1 of them phase 3. Pain · The University of Hong Kong.

Planned enrollment
3rd of 14
176 · median 103
Started
2026
with 3 others
No phase
9 of 17
3 open now
Registered
13th of 17
by date

Among the 17 studies in Pain by The University of Hong Kong, this one is the 3rd largest by planned enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2026, is one of 9 with no phase, and was the 13th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

4 of the 17 studies in Pain by The University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Pain by The University of Hong Kong, or all of them as a file.
02

Study summary

The goal of the study is to confirm the idea of AI-powered Technological Surrogate Physiotherapist (TSP), by demonstrating its effectiveness and value as a new technology-based contribution to OA healthcare. Participants will be randomized to one of two groups: (1) the conventional PT group receiving the exercise program delivered through in-person sessions; or (2) the AI-guided group following the program through the TSP after an initial PT session. All individuals will take part in the study for 12 weeks, and data will be collected at baseline and 12 weeks after randomization.

Read the detailed description

Knee pain, often caused by osteoarthritis, is a prevalent musculoskeletal disorder among older adults and significantly reduces physical function and quality of life. Exercise therapy has been shown to be an effective form of treatment for knee pain. However, the traditional delivery of exercise therapy requires that individuals attend clinics to participate in face-to-face exercise sessions, which can be expensive and inconvenient. In recent years, information technologies have been used to support the delivery of exercise programs. The programs have also shown great benefits in improving the management of knee pain. However, it remains a concern that physical therapists are not able to provide the patients with direct and immediate supervision when exercises are taken place remotely at home or in community centers, which can be detrimental to exercise performance and the management of knee pain.

Thus, the research team has developed a machine learning-based exercise training system to provide evidence-based lower limb exercise videos, real-time movement feedback, and tracking of exercise progress for older adults with knee pain. In this study, a 12-week randomized controlled non-inferiority trial will be conducted to compare the effects of the AI-powered Technological Surrogate Physiotherapist with those of in-person physiotherapy sessions.

03

Conditions studied

  • Pain
  • Knee Osteoarthritis

Keywords

  • knee pain, physical therapy, exercise
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 50 years of age;
  2. Report having knee pain most days of the week;
  3. Has radiographic evidence of grade 2, 3, or 4 knee OA on the K-L scale in the posteroanterior and/or skyline view in at least 1 knee;
  4. Willing and able, both physically and cognitively, to perform the exercises required in the study protocol;
  5. Has normal or corrected-to-normal vision;
  6. Able to speak Cantonese and read Chinese, AND
  7. Able to provide written .

Exclusion criteria

Exclusion criteria:

  1. Having a history of knee or hip replacement surgery;
  2. Being nonambulatory;
  3. Having systemic inflammatory arthritis (e.g., gout);
  4. Having a history of trauma (e.g., fractures around the knee, dislocation, sprains or tears of soft tissues like ligaments) or surgical arthroscopy of either knee within the past 6 months;
  5. Having intra-articular injection to the knee within the past 6 months;
  6. Having cognitive impairment;
  7. Involvement in a similar study (i.e., involving physical exercise or physical therapies for knee pain) within the past 6 months;
  8. Undergoing recent or imminent surgery (within 3 months) , OR
  9. Having medical co-morbidities that preclude participation in exercise.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
176 participants (estimated)

Study arms

  • Experimental
    The AI-powered Technological Surrogate Physiotherapist

    Participants will be required to perform three 30-minute exercise sessions per week for 12 weeks, with six exercises at any one time. During the exercise sessions, participants will receiveTechnological Surrogate Physiotherapist (TSP) support which will in particular leverage AI to offer innovative features and modules dedicated to enhancing exercise monitoring and supervision, real-time performance feedback, and self-assessment.

    Device: The AI-powered Technological Surrogate Physiotherapist

  • Active comparator
    Face-to-face physiotherapist-supervised exercise program

    Participants will be required to visit a physiotherapist for usual face-to-face exercise therapy. Also, they will be required to perform three 30-minute home exercise sessions per week for 12 weeks. However, TSP will not be involved in this group.

    Behavioral: Face-to-face physiotherapist-supervised exercise program

Interventions

  • DeviceThe AI-powered Technological Surrogate Physiotherapist

    The AI-powered Technological Surrogate Physiotherapist will have three key features: 1. Evidence-based exercise videos instructed by physical therapists 2. Real-time movement feedback and performance score 3. Exercise records.

  • BehavioralFace-to-face physiotherapist-supervised exercise program

    Physiotherapists will give usual face-to-face therapy. The assessment of participants' exercise movements will only be achieved in the traditional manner during face-to-face exercise sessions - by physiotherapists' visual inspection of and professional judgement on postural alignment and effectiveness, with verbal instructions for posture correction. The features of real-time movement feedback and tracking of exercise progress will not be provided.

06

What researchers measure

Primary outcomes

  1. Changes in knee pain as assessed by a 11-point numerical pain rating scale as recommended by the OARSI

    0 represents no pain and 10 represents the worst possible pain.

    Time frame: From baseline to 12 weeks

  2. Changes in physical function as assessed by the Knee Injury and Osteoarthritis Outcome Score (KOOS) physical function sub-scale

    The scale regards the degree of difficulty in performing usual daily activities and higher level activities that involve physical function of the knee. Each item will be rated on a 5-point Likert scale ranging from 'None' (i.e., no difficulty) to 'Extreme' (i.e., extreme difficulty), based on which a normalized total score will be calculated (0 indicating extreme symptoms and 100 indicating no symptoms).

    Time frame: From baseline to 12 weeks

Secondary outcomes

  1. Changes in physical function as assessed by 30-second chair-stand test

    30-second chair stand test (30CST), which measures the number of stands the participant can complete in 30 sec, will be used to assess the general leg strength and functional performance.

    Time frame: From baseline to 12 weeks

  2. Changes in physical function as assessed by timed up-and-go test

    Timed up and go (TUG) test, which measures the time it takes the participant to standup from the chair, walk 3 meters, walk back to the chair, and sit down, will be used to assess functional mobility.

    Time frame: From baseline to 12 weeks

  3. Changes in physical function as assessed by maximal isometric strength of the quadriceps and hamstrings

    The participant will be instructed to maximally extend/flex each knee for 3 trials, 3 sec each, with a 1-minute rest in between. Verbal encouragement will be given in each trial to ensure the participant makes the maximum effort. The highest force of each muscle in the three trials will be used for data analysis. After each test trial, the severity of pain experienced by the participant during the trial will be assessed using the 11-point numerical pain rating scale.

    Time frame: From baseline to 12 weeks

  4. Exercise adherence

    Exercise adherence will be indicated by the proportion of sessions and proportion of exercises performed which will be recorded by the TSP system (only for intervention group) and by participants and researchers using a log book.

    Time frame: From baseline to 12 weeks

  5. Satisfaction with the therapeutic exercise training

    It will be rated by participants using a 7-point Likert scale with anchors of 'Extremely unsatisfied' and 'Extremely satisfied'.

    Time frame: From baseline to 12 weeks

  6. Convenience in terms of location and time for accessing the exercise therapy

    It will be assessed on an 11-point numerical rating scale, with 0 representing 'Extremely inconvenient' and 10 representing 'Extremely convenient'.

    Time frame: From baseline to 12 weeks

07

Study locations

1 site
  • 826, Haking Wong Building, Pokfulam, The University of Hong Kong, Hong Kong
    Hong Kong, 000, Hong Kong
    • Kalun Or, Doctoral degree · Contactklor@hku.hk · (852) 3917-2587
    • Letong Li, Master degree · Sub investigator
08

References and documents

Publications

  • Roberts JM, Wilson K. Effect of stretching duration on active and passive range of motion in the lower extremity. Br J Sports Med. 1999 Aug;33(4):259-63. doi: 10.1136/bjsm.33.4.259. PubMed 10450481 ↗
  • Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991 Feb;39(2):142-8. doi: 10.1111/j.1532-5415.1991.tb01616.x. PubMed 1991946 ↗
  • Hinman RS, Kimp AJ, Campbell PK, Russell T, Foster NE, Kasza J, Harris A, Bennell KL. Technology versus tradition: a non-inferiority trial comparing video to face-to-face consultations with a physiotherapist for people with knee osteoarthritis. Protocol for the PEAK randomised controlled trial. BMC Musculoskelet Disord. 2020 Aug 7;21(1):522. doi: 10.1186/s12891-020-03523-8. PubMed 32767989 ↗
  • Lam CL, Tse EY, Gandek B, Fong DY. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol. 2005 Aug;58(8):815-22. doi: 10.1016/j.jclinepi.2004.12.008. PubMed 16018917 ↗
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83. PubMed 1593914 ↗
  • Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, Buchbinder R, Snyder-Mackler L, Henrotin Y, Thumboo J, Hansen P, Bennell KL. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthritis Cartilage. 2013 Aug;21(8):1042-52. doi: 10.1016/j.joca.2013.05.002. Epub 2013 May 13. PubMed 23680877 ↗
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available. PubMed 22588748 ↗
  • McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, Wang S, Schnitzer T. OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthritis Cartilage. 2015 May;23(5):747-60. doi: 10.1016/j.joca.2015.03.005. PubMed 25952346 ↗
  • McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. Br J Rheumatol. 1992 Mar;31(3):189-92. doi: 10.1093/rheumatology/31.3.189. PubMed 1540789 ↗
  • Cottrell E, Roddy E, Foster NE. The attitudes, beliefs and behaviours of GPs regarding exercise for chronic knee pain: a systematic review. BMC Fam Pract. 2010 Jan 18;11:4. doi: 10.1186/1471-2296-11-4. PubMed 20082694 ↗
  • Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Patel A, Williamson E, Jones RH, Dieppe PA, Reeves BC. Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum. 2007 Oct 15;57(7):1211-9. doi: 10.1002/art.22995. PubMed 17907147 ↗
  • Hurley MV, Walsh NE, Mitchell H, Nicholas J, Patel A. Long-term outcomes and costs of an integrated rehabilitation program for chronic knee pain: a pragmatic, cluster randomized, controlled trial. Arthritis Care Res (Hoboken). 2012 Feb;64(2):238-47. doi: 10.1002/acr.20642. PubMed 21954131 ↗
  • Chen T, Or CK, Chen J. Effects of technology-supported exercise programs on the knee pain, physical function, and quality of life of individuals with knee osteoarthritis and/or chronic knee pain: A systematic review and meta-analysis of randomized controlled trials. J Am Med Inform Assoc. 2021 Feb 15;28(2):414-423. doi: 10.1093/jamia/ocaa282. PubMed 33236109 ↗
  • Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, Blenkinsopp A, Sim J. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ. 2006 Nov 11;333(7576):995. doi: 10.1136/bmj.38977.590752.0B. Epub 2006 Oct 20. PubMed 17056608 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Jun 2027, 13 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 13 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2021
First posted
Dec 29, 2021
StartEst.
May 20, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Sep 1, 2027
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05173064
Responsible party
Sponsor
First posted
Dec 29, 2021
Start date
May 20, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Jun 4, 2026

Study contacts

Calvin Kalun Or, PhD
Contact
klor@hku.hk
(852) 3917-2587

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion